USP accepting comments on pending monographs

Published March 5, 2021

Did you know that USP allows input for its Pending Monograph Program? Now you do. The organization doesn’t make a formal announcement the way, say, FDA would, but it does publish ‘notices of intent’ for revisions, and “All stakeholders are encouraged to comment on new monograph proposals and revision proposals.”

Click here for the current list of compendial notices for the monograph program.

And click here for an explanation of the process.